越南成人接种AZD1222疫苗后不良事件影响因素分析
2021年7月对1028名接种至少一剂AZD1222的越南成人进行在线横断面调查,仅3.9%无不良事件,2.4%报告严重症状;女性胃肠道症状更频繁,年龄和剂次增加与自报不良事件频率降低相关。
要点
- 接种AZD1222后常见不良事件为中度发热(69.4%)、肌肉酸痛(68.6%)和疲劳/嗜睡(62.5%)。
- 女性报告胃肠道不良事件比男性更频繁。
- 年龄增长和接种剂次增加与自报不良事件频率降低相关。
核心结论
- 性别、年龄和疫苗剂次是影响越南成人接种AZD1222后不良事件的重要因素。
研究设计与样本
- 2021年7月开展的在线横断面调查,纳入1028名18岁以上、接种至少一剂AZD1222的越南人。
主要发现
- 仅40/1028(3.9%)报告无任何不良事件,25/1028(2.4%)报告严重症状。
- 最常见不良事件为中度发热(69.4%)、肌肉酸痛(68.6%)、疲劳/嗜睡(62.5%)、身体酸痛(59.4%)、头痛(58.5%)、注射部位疼痛(58.3%)和寒战(45.7%)。
- 女性比男性更频繁报告胃肠道不良事件。
- 年龄增加或疫苗剂次增加与自报不良事件频率降低相关。
临床怎么用
- 接种AZD1222前可告知接种者常见不良事件及性别、年龄和剂次对报告频率的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19 vaccines have been speedily developed and deployed. The more vaccine doses are delivered to users, the more common adverse events following immunization (AEFI) are reported. This study aimed to identify factors affecting AEFI in Vietnamese people receiving the COVID-19 vaccine AZD1222 developed by AstraZeneca and Oxford University. METHODS: In July 2021, an online cross-sectional survey was conducted among Vietnamese who have been vaccinated with COVID-19 vaccines. The questionnaire collected demographic characteristics, medical history, types of injected vaccines, common AEFI, and post-vaccination activities from respondents. The effects of host-related factors on AEFI including 24 specific symptoms were also explored. RESULTS: After screening, 1028 participants who were Vietnamese, over 18 years old and received at least one dose of AZD1222, were included in the study. Only 40/1028 (3.9%) participants reported not having any AEFI, whereas 25/1028 (2.4%) reported to have severe symptoms. The most common AEFI were moderate fever (69.4%), muscle aches (68.6%), followed by fatigue/ sleepiness (62.5%), body aches (59.4%), headache (58.5%), pain at injection site (58.3%) and chills (45.7%). Data analysis showed that females complained about AEFI particularly gastrointestinal symptoms more frequently than males. Age of participants and number of doses were also important factors affecting AEFI as the increase of age or number of vaccine doses was associated with the decrease of self-reported AEFI frequency. CONCLUSIONS: This study provides a detailed assessment of risk factors associated with AEFI in Vietnamese people vaccinated with AZD1222. It seems that gender, age and vaccine doses are important factors affecting AEFI.
引用
- Tran VN, Nguyen HA, Le TTA, et al. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021. Vaccine. 2021. PMID: 34607748. doi:10.1016/j.vaccine.2021.09.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。